Key result
Insulin resistance in essential hypertension was not associated with vascular abnormalities, though insulin-sensitive patients tended to have greater clamp-induced vasodilatation (53% vs 9%, P=0.06).
Why the study?
Is metabolic insulin resistance associated with abnormalities in vascular structure or reactivity in male patients with untreated essential hypertension?
Cross-Sectional (n=29)
Is metabolic insulin resistance associated with abnormalities in vascular structure or reactivity in male patients with untreated essential hypertension?
Absolute Event Rate: 9% vs 53%
p-value: p=.06
Metabolic insulin resistance in essential hypertension is not associated with abnormalities in vascular structure or adrenergic/endothelial reactivity.
Insulin resistance warrants no vascular assessment change in essential hypertension; leaves open dissociation from vascular insulin sensitivity.
BACKGROUND: Insulin resistance and vascular abnormalities have both been described in patients with essential hypertension. Whether these defects are associated with one another in the same individual has not been established. METHODS AND RESULTS: Whole-body insulin sensitivity (by the insulin clamp technique), forearm minimal vascular resistances, and the dose-response curve to acetylcholine, sodium-nitroprusside, and norepinephrine were measured in a group of 29 male patients with untreated essential hypertension. When the patients were divided into tertiles according to their level of insulin sensitivity, resistant and sensitive hypertensives were matched on several potential confounders of insulin action and vascular function. These subgroups showed similar minimal vascular resistances (2.5+/-0.2 versus 3.2+/-0.6 mm Hg per mL x min(-1) x dL(-1)) and superimposable responses to graded intraarterial infusions of acetylcholine, sodium-nitroprusside, and norepinephrine. No correlation was found between the vascular parameters (slope of the curve or maximal response) and insulin-mediated glucose uptake in the whole group. During the clamp, insulin sensitive patients tended to have greater increments in forearm blood flow when compared to their insulin resistant counterparts (+53+/-21 versus +9+/-7%, P=.06); in the whole group, clamp-induced vasodilatation was weakly related to insulin-mediated glucose uptake (r=.44, P<.02) as well as to the slope of the acetylcholine dose-response curve (r=.40, P<.04). Together, these two responses explained 30% (multiple r=.55, P<.01) of the variability in insulin-induced vasodilatation. CONCLUSIONS: Metabolic insulin resistance in essential hypertension is not associated with abnormalities in vascular structure, acetylcholine or nitroprusside-induced vasodilatation, or vascular adrenergic reactivity. Degree of insulin sensitivity and acetylcholine sensitivity explain a small portion of the variability of the clamp-induced vasodilatation in hypertensive patients.
No takes yet. Share an insight, caveat, or question.
Natali et al. (1997) conducted a cross-sectional in untreated essential hypertension (n=29). Insulin resistance vs. Insulin sensitivity was evaluated on Increment in forearm blood flow during insulin clamp (p=.06). Insulin resistance in essential hypertension was not associated with vascular abnormalities, though insulin-sensitive patients tended to have greater clamp-induced vasodilatation (53% vs 9%, P=0.06).
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: